BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 27539625)

  • 1. Precision Monitoring by Next-Generation Sequencing in Lymphoma: Circulating Tumor DNA as a New Biomarker.
    Gordon LI
    Oncology (Williston Park); 2016 Aug; 30(8):745-6. PubMed ID: 27539625
    [No Abstract]   [Full Text] [Related]  

  • 2. Somatic mutations of cell-free circulating DNA detected by targeted next-generation sequencing and digital droplet PCR in classical Hodgkin lymphoma.
    Bessi L; Viailly PJ; Bohers E; Ruminy P; Maingonnat C; Bertrand P; Vasseur N; Beaussire L; Cornic M; Etancelin P; Camus V; Picquenot JM; Tilly H; Stamatoullas A; Jardin F
    Leuk Lymphoma; 2019 Feb; 60(2):498-502. PubMed ID: 30068243
    [No Abstract]   [Full Text] [Related]  

  • 3. Circulating Tumor DNA Mutation Profiling by Targeted Next Generation Sequencing Provides Guidance for Personalized Treatments in Multiple Cancer Types.
    Shu Y; Wu X; Tong X; Wang X; Chang Z; Mao Y; Chen X; Sun J; Wang Z; Hong Z; Zhu L; Zhu C; Chen J; Liang Y; Shao H; Shao YW
    Sci Rep; 2017 Apr; 7(1):583. PubMed ID: 28373672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic monitoring of circulating tumor DNA in non-Hodgkin lymphoma.
    Roschewski M; Staudt LM; Wilson WH
    Blood; 2016 Jun; 127(25):3127-32. PubMed ID: 27081097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-free circulating tumor DNA supplementing tissue biopsies for identification of targetable mutations: Implications for precision medicine and considerations for reconciling results.
    Hicks JK; Saller J; Wang E; Boyle T; Gray JE
    Lung Cancer; 2017 Sep; 111():135-138. PubMed ID: 28838384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating tumor DNA for personalized lung cancer monitoring.
    Fiala C; Diamandis EP
    BMC Med; 2017 Aug; 15(1):157. PubMed ID: 28814291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Exploratory study of circulating tumor DNA detection in early breast cancer: an analysis of 75 next-generation sequencing results].
    Zhou B; Xin L; Xu L; Liu YH; Zhang MM; Jing RL; Liang XY; Cao SB
    Zhonghua Wai Ke Za Zhi; 2017 Nov; 55(11):847-852. PubMed ID: 29136733
    [No Abstract]   [Full Text] [Related]  

  • 8. Correlation of genomic alterations assessed by next-generation sequencing (NGS) of tumor tissue DNA and circulating tumor DNA (ctDNA) in metastatic renal cell carcinoma (mRCC): potential clinical implications.
    Hahn AW; Gill DM; Maughan B; Agarwal A; Arjyal L; Gupta S; Streeter J; Bailey E; Pal SK; Agarwal N
    Oncotarget; 2017 May; 8(20):33614-33620. PubMed ID: 28431395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-Throughput and Sensitive Quantification of Circulating Tumor DNA by Microfluidic-Based Multiplex PCR and Next-Generation Sequencing.
    Guan Y; Mayba O; Sandmann T; Lu S; Choi Y; Darbonne WC; Leveque V; Ryner L; Humke E; Tam NWR; Sujathasarma S; Cheung A; Bourgon R; Lackner MR; Wang Y
    J Mol Diagn; 2017 Nov; 19(6):921-932. PubMed ID: 28867605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic value of clonal heterogeneity and quantitative assessment of plasma circulating clonal IG-VDJ sequences at diagnosis in patients with follicular lymphoma.
    Sarkozy C; Huet S; Carlton VE; Fabiani B; Delmer A; Jardin F; Delfau-Larue MH; Hacini M; Ribrag V; Guidez S; Faham M; Salles G
    Oncotarget; 2017 Jan; 8(5):8765-8774. PubMed ID: 28060738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating Cell-Free Tumor DNA Analysis of 50 Genes by Next-Generation Sequencing in the Prospective MOSCATO Trial.
    Jovelet C; Ileana E; Le Deley MC; Motté N; Rosellini S; Romero A; Lefebvre C; Pedrero M; Pata-Merci N; Droin N; Deloger M; Massard C; Hollebecque A; Ferté C; Boichard A; Postel-Vinay S; Ngo-Camus M; De Baere T; Vielh P; Scoazec JY; Vassal G; Eggermont A; André F; Soria JC; Lacroix L
    Clin Cancer Res; 2016 Jun; 22(12):2960-8. PubMed ID: 26758560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biopsy-free circulating tumor DNA assay identifies actionable mutations in lung cancer.
    Villaflor V; Won B; Nagy R; Banks K; Lanman RB; Talasaz A; Salgia R
    Oncotarget; 2016 Oct; 7(41):66880-66891. PubMed ID: 27602770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-Specific Mitochondrial DNA Variants Are Rarely Detected in Cell-Free DNA.
    Weerts MJA; Timmermans EC; van de Stolpe A; Vossen RHAM; Anvar SY; Foekens JA; Sleijfer S; Martens JWM
    Neoplasia; 2018 Jul; 20(7):687-696. PubMed ID: 29842994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of mutant alleles in circulating tumor DNA can predict survival in lung cancer.
    Yang X; Zhuo M; Ye X; Bai H; Wang Z; Sun Y; Zhao J; An T; Duan J; Wu M; Wang J
    Oncotarget; 2016 Apr; 7(15):20810-24. PubMed ID: 26989078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating Tumor DNA to Monitor Therapy for Aggressive B-Cell Lymphomas.
    Kwok M; Wu SP; Mo C; Summers T; Roschewski M
    Curr Treat Options Oncol; 2016 Sep; 17(9):47. PubMed ID: 27461036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Monitoring of Cell-Free Circulating Tumor DNA in Non-Hodgkin Lymphoma.
    Melani C; Roschewski M
    Oncology (Williston Park); 2016 Aug; 30(8):731-8, 744. PubMed ID: 27539624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of clinically relevant early genomic lesions in B-cell malignancies from circulating tumour DNA using a single hybridisation-based next generation sequencing assay.
    Blombery PA; Ryland GL; Markham J; Guinto J; Wall M; McBean M; Jones K; Thompson ER; Cameron DL; Papenfuss AT; Prince MH; Dickinson M; Westerman DA
    Br J Haematol; 2018 Oct; 183(1):146-149. PubMed ID: 28880377
    [No Abstract]   [Full Text] [Related]  

  • 18. Hypermutated Circulating Tumor DNA: Correlation with Response to Checkpoint Inhibitor-Based Immunotherapy.
    Khagi Y; Goodman AM; Daniels GA; Patel SP; Sacco AG; Randall JM; Bazhenova LA; Kurzrock R
    Clin Cancer Res; 2017 Oct; 23(19):5729-5736. PubMed ID: 28972084
    [No Abstract]   [Full Text] [Related]  

  • 19. Molecular Monitoring of Lymphomas.
    Schroers-Martin JG; Alig S; Garofalo A; Tessoulin B; Sugio T; Alizadeh AA
    Annu Rev Pathol; 2023 Jan; 18():149-180. PubMed ID: 36130071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early solid tumor diagnosis through next-generation sequencing of cell-free DNA.
    Ziogas DE; Kyrochristos ID; Lykoudis EG; Roukos DH
    Biomark Med; 2018 Nov; 12(11):1197-1201. PubMed ID: 30379093
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.